# Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

> **Open Intelligence Dossier** · First detected: 2026-10-23 03:00 UTC · Category: Business

## Executive Summary
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%" is generating significant coverage in the Business category, with 1 articles from 1 distinct sources tracked by PULSE so far.


Outlets currently covering the story include The Guardian. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| The Guardian | ‘Bespoke’ mRNA vaccine significantly reduces risk of melanoma recurrence or death, clinical trial shows | [Source Link](https://news.google.com/rss/articles/CBMioAFBVV95cUxOQUtvY3pZb3RlNjQ1Um1HTHE5Q0E1RklTMG1abU1RSEM5OUg0c0NEaTJnZUtlMDVoZ1pXYW9oQkhib0Voc2UtTGE2NUtWcmpJaV9BODc5T1g4d3lCZ0hneGN6dE1hWUxPQlJaOC14QmQ1NFJ2MzZHelJMUkVWWkN6UThub3BIVUxkTGxLckd0R1czX1lld2EzNEVLbS1sT2JC?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-10-23/moderna-and-merck-say-their-mrna-cancer-vaccine-cut-death-recurrence-by-42*